Skip to content

Chest CT-scan for the Diagnosis of Community-acquired Pneumonia

Chest CT-scan for the Diagnosis of Community-acquired Pneumonia in Patients Visiting the Emergency Department

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01574066
Acronym
PACSCAN
Enrollment
339
Registered
2012-04-10
Start date
2011-11-30
Completion date
2013-07-31
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-acquired Pneumonia, Dyspnea

Keywords

Community-acquired pneumonia, Diagnosis, Emergency medicine, Chest CT-scan

Brief summary

Primary objective : to estimate impact of CT-scan on diagnostic for emergency department (ED) patients with suspected Community-acquired Pneumonia (CAP). Secondary objective: to estimate impact of CT-scan on treatment (antimicrobial therapy) and site of care for ED patients with suspected CAP.

Detailed description

Rational: Community-acquired pneumonia (CAP) is a frequent infectious disorder in patients visiting the ED. CAP is responsible for high morbidity and associated-mortality is increasing in Western countries. CAP corresponds to invasion of the lung by pathogens. Diagnosis depends on clinical and X-ray assessment. However, these signs and symptoms are poorly specific and are often lacking. As prognosis depends on precocious and fitted antimicrobial treatment, making CAP diagnosis in a short time span (4-8 hours) is mandatory. Preliminary studies suggest that chest CT-scan could over-performed X-ray for diagnosis of CAP. Consensus conferences suggest the use of CT-scan in patients with uncertain diagnosis and unusual presentation and outcome. Because CT-scan is currently easily available, its use in a first intent is questionable for ED patients with suspected CAP. Primary objective: to estimate impact of CT-scan on diagnostic for ED patients with suspected CAP. Secondary objective: to estimate impact of CT-scan on treatment (antimicrobial therapy) and site of care for ED patients with suspected CAP. Prospective multicenter study to measure chest CT-scan impact. 350 patients visiting the ED of 4 inner tertiary teaching hospitals in Paris, France, with suspected CAP. Management: Patients will be managed according to current guidelines, including conventional chest X-ray. Evaluation criteria. Attending ED physicians will implement pre- and post-test proforma for diagnosis (CAP) level of certainty, treatment (antimicrobial agents), site of care, before and after chest CT-scan. Comparison of ED physician's answers before/after CT-scan. Patients will be followed until day 28. An adjudication committee (1 pneumologist, 1 infectiologist, 1 radiologist)will review patients' data for gold standard diagnosis. Statistical considerations: The investigators hypothesize that chest CT-scan wil modify diagnosis certainty in 20%. This implies that 300 participants should be enrolled to allow assessment of changes in 15 % et 25 %. Undue changes will be calculated a posteriori when diagnosis gold standard will be established by adjudication committee. Anticipated results: Chest CT-scan should improve diagnosis certainty, treatment and site-of-care in patients visiting the ED with suspected CAP. If this is observed in at least 20%, the investigators will measure impact of chest CT-scan in a prospective randomized interventional study.

Interventions

PROCEDUREChest CT-scan

Patients with a suspicion of acquired pneumonia visiting the emergency department will do a chest CT-scan

Sponsors

URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient above 18 years of age * Patient with a presumptive diagnosis of CAP according to attending ED physician * Patient experiencing at least one systemic sign (T°\>38°C or \< 36°C, HR\>90/min, RR\>20/min) * Patient experiencing one respiratory sign (cough, lateral chest pain, localized crackles, dyspnea) that recently appeared * Patient with a prior medical examination, the results have been or will be communicated * Patient gave written informed consent or in cases of emergency parent/ support person who gave written informed consent if he/she is present on the day of inclusion

Exclusion criteria

* Pregnancy * Patient with shock * Patient with respiratory distress and immune suppression * Patient with other criteria for immediate ICU referral to ICU * Patient with living conditions making it impossible to follow 28 days * Patient not affiliated with a social security system

Design outcomes

Primary

MeasureTime frameDescription
Chest CT-scanin 28 daysPercentage of diagnoses modified by chest CT-scan.

Secondary

MeasureTime frameDescription
Treatments changesin 28 daysPercentage of treatments changes (antimicrobial therapy) modified by chest CT-scan
Changes of site-of-carein 28 daysPercentage of site-of-care (admission/non admission) modified by chest CT-scan
Identification of viral and bacterial agentsat day of inclusion (day 1)Identification of viral and bacterial agents from nasal and pharyngeal swabs
Markers of infection in the bloodat day of inclusion (day 1)Determination of markers of infection in the blood
Markers of infection and markers of inflammation in urineat day of inclusion (day 1)Determination of markers of infection and of inflammation in urine

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026